Area of research
Reproductive Medicine · Obstetrics and Gynecology
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, Growth Hormone and Insulin-like Growth Factors, and PARP inhibition in cancer therapy.
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer
#554 Is there a prognostic value for the positive lymph-node ratio? An israeli gynecologic oncology group study
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Postoperative radiation rates in stage IIA1 cervical cancer: Is surgical treatment justified? An Israeli Gynecologic Oncology Group Study
Integration of PET/CT Into the Preoperative Evaluation of Patients With Early Cervical Cancer Does Not Decrease the Proportion of Patients With Positive Lymph Nodes Found After Surgery
Weekly Topotecan for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma